Form 4: Director Lance Berberian Receives Privia Health Equity Grant

Privia Health Group director Lance Berberian was granted 8,463 restricted stock units as part of the company's 2021 Omnibus Incentive Plan.

Summary

• Director Lance Berberian acquired 8,463 restricted stock units (RSUs) of Privia Health Group, Inc. (PRVA) common stock.
• The transaction occurred on May 20, 2026, at a price of $0 per share as part of an equity incentive grant.
• Following this transaction, the reporting person's total beneficial ownership increased to 16,131 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation that does not signal a change in company strategy or financial health.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.
• Standard equity grant under the established 2021 Omnibus Incentive Plan.

Negatives

• None identified; this is a routine compensatory equity grant.

Risks

• Standard market risks associated with equity ownership in the healthcare services sector.

Future Outlook

The RSUs are scheduled to vest on the earlier of the day before the 2027 annual meeting of stockholders or the first anniversary of the grant date.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practices designed to incentivize long-term oversight and alignment with shareholder interests in the healthcare technology and services industry.

Comparison to Industry Standards

• The grant structure is consistent with standard equity compensation practices for board members in mid-cap healthcare companies.
• Vesting schedules align with typical one-year cliff or annual meeting-based vesting cycles observed in the sector.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard compensatory grant.

Next Steps

• Vesting of the 8,463 RSUs on the earlier of the 2027 annual meeting or May 20, 2027.

Key Dates

Keywords

Privia Health, PRVA, Form 4, Insider Trading, Equity Compensation, Director Ownership